Research indicates hospitals contribute to the local spread of antibiotic-resistant infections.
A recent study published in the journal Infection Control & Hospital Epidemiology by the Society for Healthcare Epidemiology of America suggests that family members of patients discharged from hospitals may be at an increased risk of contracting antibiotic-resistant infections, commonly referred to as superbugs. This risk persists even if the patient themselves was not diagnosed with such an infection, indicating that hospitals may contribute to the spread of resistant bacteria in the community.
When recently hospitalized patients were diagnosed with the superbug — Methicillin-resistant Staphylococcus aureus infection (MRSA) — the risk to relatives living with them was even higher. The longer the relative's hospital stay, even without a MRSA diagnosis, the higher the risk to family members.
"Patients can become colonized with MRSA during their hospital stay and transmit MRSA to their household members," said Aaron Miller, PhD, lead researcher on the study and research assistant professor of internal medicine-infectious diseases at the University of Iowa. "This suggests hospitals contribute to the spread of MRSA into the community through discharged patients who are asymptomatic carriers."
Recommendations for Hospitals
Miller recommends hospitals enhance infection control practices, including testing for MRSA colonization, especially at discharge, even with there are no symptoms of infection. He said MRSA colonization and infections could be tracked among hospital patients and their household contacts to identify and mitigate transmission more effectively.
"This important study illustrates the risk of spread of resistant pathogens related to healthcare and highlights the essential importance of core infection practices," said SHEA President Thomas Talbot, M.D., chief hospital epidemiologist at Vanderbilt University Medical center. Talbot was not involved with the research. "Hand hygiene, environmental cleaning, and standard interventions to reduce Staphylococcal colonization are crucial to preventing the spread of resistant bacteria in healthcare settings."
Understanding MRSA
MRSA infections are known as superbugs because they do not respond to common antibiotics, making them difficult to treat. MRSA generally occurs in people who have been in a hospital or another healthcare setting, such as a nursing home, but MRSA also spreads in communities outside the hospital, usually through skin-to-skin contact. Most people with MRSA have no symptoms, but the bacteria can cause painful swelling if it gets under the skin, and it can be deadly if it spreads to other parts of the body, such as blood or lungs.
Researchers used a large database of insurance claims that included 158 million enrollees with two or more family members on the same plan to learn about how MRSA spread after someone in a household had been in the hospital.
Reviewing 424,512 MRSA cases among 343,524 insured people, the study found 4,724 cases of MRSA being potentially transmitted to a family member from a relative who had recently been in the hospital and had a diagnosis of MRSA. They also found 8,064 potential transmissions of MRSA after the hospitalization of a family member who did not have an MRSA infection.
"It is important not to over-emphasize the hospital stay risk," Miller said. "While we identified a significant risk factor for transmission in the household and community the absolute risk remains relatively low."
People exposed to a recently hospitalized family member with MRSA were more than 71 times, or 7000%, more likely to get an MRSA infection compared to enrollees who did not have a family member who had been hospitalized or exposed to MRSA in the previous 30 days.
Having a family member in the household who was hospitalized but did not have MRSA increased the chances of a relative getting MRSA in the month after discharge by 44%.
The more time the family member spent in the hospital, the higher the likelihood that someone in their household would get MRSA. If the patient was in the hospital for one to three days in the previous month, the chance of a relative getting MRSA increased by 34% compared to people with no recent hospitalizations in their household. If a family member was hospitalized for four to 10 days, the chances of MRSA infection in a relative were 49% higher, and with hospitalizations longer than 10 days the odds of a relative in the same household getting an infection rose by 70% to 80%.
Other factors associated with MRSA infections among household members included the number of other illnesses, prior antibiotic usage, and the presence of young children in the family.
Reference: "Hospitalizations among family members increase the risk of MRSA infection in a household" by Aaron C. Miller, Alan T. Arakkal, Daniel K. Sewell, Alberto M. Segre, Bijaya Adhikari, Philip M. Polgreen and For The CDC MInD-Healthcare Group, 7 August 2024, Infection Control & Hospital Epidemiology.
DOI: 10.1017/ice.2024.106
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]















